Lactated Ringer's and Amiodarone Are NOT Compatible
Lactated Ringer's solution should not be co-administered with intravenous amiodarone through the same line or Y-site connector, as they are physically incompatible and will form precipitates. 1, 2
Evidence from FDA Drug Label
The FDA-approved amiodarone prescribing information explicitly states that amiodarone infusions exceeding 2 hours must be administered in glass or polyolefin bottles containing D5W (5% Dextrose in Water) 1. The drug label provides a specific incompatibility table listing drugs that form precipitates when mixed with amiodarone in D5W, and emphasizes that if coadministration of incompatible drugs is necessary, separate intravenous administration lines must be used 1.
Research Confirmation
A 2020 compatibility study directly tested amiodarone with both Plasma-Lyte A and Lactated Ringer's solution using turbidimetric analysis. Amiodarone demonstrated turbidimetric incompatibility when combined with either Plasma-Lyte A or Lactated Ringer's and should not be co-administered with either of these fluids via Y-site connector 2. This study used maximum concentrations for patient administration and assessed compatibility at time of mixing and at 15-minute intervals up to one hour.
Clinical Implications
- Use only D5W as the diluent for amiodarone infusions 1
- If a patient requires both amiodarone and crystalloid resuscitation, use separate dedicated IV lines
- For amiodarone concentrations >2 mg/mL, a central venous catheter is required to prevent peripheral vein phlebitis 1
- Concentrations >3 mg/mL in D5W are associated with high incidence of peripheral vein phlebitis 1
Common Pitfall to Avoid
Do not attempt to run amiodarone through the same line as Lactated Ringer's or other balanced crystalloid solutions, even if using a Y-site connector. The physical incompatibility will result in precipitation, potentially causing catheter occlusion, underdosing of amiodarone, and embolic risk from particulate matter.